Development of a novel scoring system based on endoscopic appearance for management of rectal neuroendocrine tumors

Abstract

Background The clinical significance of the endoscopic appearance of rectal neuroendocrine tumors (NETs) is poorly understood. We aimed to develop a novel scoring system based on endoscopic appearances to predict endoscopically advanced disease in patients with rectal NETs when initially diagnosed.

Methods Patients diagnosed with well-differentiated rectal NETs between January 2005 and December 2019 were retrospectively included. Logistic regression analyses were applied to study the relationship between endoscopic appearance and advanced disease. The whole dataset was randomly divided into training and validation sets, which were used to develop and validate a novel scoring system, respectively.

Results 309 patients were included. The endoscopic appearance of rectal NETs was significantly associated with advanced disease (P < 0.001). A novel scoring system was developed based on endoscopic appearance, including tumor size, tumor shape, and mucosal surface, using the training set. The area under curve (AUC) of the scoring system to predict advanced disease was 0.953 (95 % confidence interval [CI] 0.915 – 0.991; P < 0.001) and 0.960 (95 %CI 0.905 – 1.000; P < 0.001) in the training and validation sets, respectively. Furthermore, the scoring system was significantly associated with tumor grade. Patients with high scores had significantly worse disease-free and overall survival than patients with low scores (P < 0.001).

Conclusion This novel scoring system based on the endoscopic appearance of the primary tumor can help to accurately identify patients with endoscopically advanced disease who are not suitable for endoscopic resection. In addition, it is of great value in monitoring tumor recurrence and overall survival in patients with rectal NETs.

^* Contributed equally to this work.

Publication History

Received: 09 June 2020

Accepted: 29 September 2020

Accepted Manuscript online:
29 September 2020

Article published online:
16 December 2020

• References

• 1 Yao JC, Hassan M, Phan A. et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063-3072
• 2 Dasari A, Shen C, Halperin D. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 2017; 3: 1335-1342
• 3 Ramage JK, De Herder WW, Delle Fave G. et al. ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms. Neuroendocrinology 2016; 103: 139-143
• 4 NCCN. NCCN Clinical PracticeGuidelines in Oncology: Neuroendocrine tumors. V.1.2019. Available at: https://www.nccn.org/professionals/physician_gls/
• 5 Chen T, Yao LQ, Xu MD. et al. Efficacy and safety of endoscopic submucosal dissection for colorectal carcinoids. Clin Gastroenterol Hepatol 2016; 14: 575-581
• 6 Park SS, Han KS, Kim B. et al. Comparison of underwater endoscopic mucosal resection and endoscopic submucosal dissection of rectal neuroendocrine tumors (with videos). Gastrointest Endosc 2020; 91: 1164-1171 e1162
• 7 Sui QQ, Lin JZ, Peng JH. et al. Local surgical excision versus endoscopic resection for rectal carcinoid: A meta-analysis. J Cancer 2017; 8: 3969-3974
• 8 Shim KN, Yang SK, Myung SJ. et al. Atypical endoscopic features of rectal carcinoids. Endoscopy 2004; 36: 313-316
• 9 Kim BN, Sohn DK, Hong CW. et al. Atypical endoscopic features can be associated with metastasis in rectal carcinoid tumors. Surg Endosc 2008; 22: 1992-1996
• 10 Nagtegaal ID, Odze RD, Klimstra D. et al. WHO Classification of Tumours. Digestive System Tumours. Fifth Edition.. Lyon: World Health Organization Press; 2019
• 11 Genc CG, Jilesen AP, Partelli S. et al. A new scoring system to predict recurrent disease in grade 1 and 2 nonfunctional pancreatic neuroendocrine tumors. Ann Surg 2018; 267: 1148-1154
• 12 Mosquera C, Fitzgerald TL, Vora H. et al. Novel nomogram combining depth of invasion and size can accurately predict the risk for regional nodal metastases for appendiceal neuroendocrine tumors (A-NET). J Surg Oncol 2017; 116: 651-657
• 13 Gamboa AC, Liu Y, Lee RM. et al. A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique. J Surg Oncol 2019; 120: 932-939
• 14 Ngamruengphong S, Kamal A, Akshintala V. et al. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors. Gastrointest Endosc 2019; 89: 602-606
• 15 Park SB, Kim DJ, Kim HW. et al. Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors?. World J Gastroenterol 2017; 23: 2037-2043